Objectives The aim of the study was to evaluate the healing process at 12 months after
ABSORB™ bioresorbable vascular scaffold (BVS) implantation in patients with ST‐segment …

Aim: To evaluate 12-month clinical outcome, safety and effectiveness of BVS implantation in
complex lesions and in stable angina (SA) or ACS. Material and methods: Five hundred …

Background The bioresorbable vascular scaffold (BVS) represents a novel technology
designed to overcome the long-term limitations of metallic coronary stent implantation in …

Background Little data are available on the long-term outcomes of bioresorbable scaffold
(BRS) in the setting of ST-segment elevation myocardial infarction (STEMI). The aim of this …

Abstract Aims Data on Absorb bioresorbable vascular scaffold (BVS) use in patients
presenting with ST-segment elevation myocardial infarction (STEMI) are limited …

Background: Multislice computed tomography (MSCT) offers a non-invasive method of
imaging bioresorbable scaffolds (BRS). Objectives: To investigate the advantages and …

Aims: The aim of this study was to report on the midterm outcomes of patients undergoing
percutaneous coronary intervention with bioresorbable vascular scaffolds (BVS) for the …

Objectives To assess the feasibility and the clinical results following a prespecified
bioresorbable vascular scaffold (Absorb BVS) implantation strategy in ST‐elevation …

ST-segment elevation myocardial infarction (STEMI) represents a challenging and
appealing clinical scenario for the physiological advantages of bioresorbable vascular …